It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Are you implying that this fact somehow negates the serious flaws contained in the original study? Or are you so blinded by your agreement with the study's conclusions that you're unable to see that those flaws exist? You shouldn't accept bad science just because you like the results.
FDA encourages developers of GE plants to consult with the agency before marketing their products. Although the consultation is voluntary, Keefe says developers find it helpful in determining the steps necessary to ensure that food products made from their plants are safe and otherwise lawful.
dusty1
reply to post by opopanax
The conflict of interest here is undeniable.
dusty1
Perhaps you can break down the study for us and explain where the researcher went wrong.
The biggest criticism from both reviews is that Séralini and his team used only ten rats of each sex in their treatment groups. That is a similar number of rats per group to that used in most previous toxicity tests of GM foods, including Missouri-based Monsanto’s own tests of NK603 maize. Such regulatory tests monitor rats for 90 days, and guidelines from the Organisation for Economic Co-operation and Development (OECD) state that ten rats of each sex per group over that time span is sufficient because the rats are relatively young. But Séralini’s study was over two years — almost a rat’s lifespan — and for tests of this duration, the OECD recommends at least 20 rats of each sex per group for chemical-toxicity studies, and at least 50 for carcinogenicity studies.
Moreover, the study used Sprague-Dawley rats, which both reviews note are prone to developing spontaneous tumours. Data provided to Nature by Harlan Laboratories, which supplied the rats in the study, show that only one-third of males, and less than one-half of females, live to 104 weeks. By comparison, its Han Wistar rats have greater than 70% survival at 104 weeks, and fewer tumours. OECD guidelines state that for two-year experiments, rats should have a survival rate of at least 50% at 104 weeks. If they do not, each treatment group should include even more animals — 65 or more of each sex.
Unequivocally, the Editor-in-Chief found no evidence of fraud or intentional misrepresentation of the data. However, there is a legitimate cause for concern regarding both the number of animals in each study group and the particular strain selected.
[...]
Ultimately, the results presented (while not incorrect) are inconclusive, and therefore do not reach the threshold of publication for Food and Chemical Toxicology.
dusty1
The new Associate Editor of the FCT which retracted the study, used to work for Monsanto.
I would agree with you if it was the sole decision of Richard Goodman to retract the study (it wasn't), in spite of the study itself appearing sound (it doesn't).
Our mission
The mission of the Organization for Economic Co-operation and Development (OECD) is to promote policies that will improve the economic and social well-being of people around the world.
The OECD provides a forum in which governments can work together to share experiences and seek solutions to common problems. We work with governments to understand what drives economic, social and environmental change. We measure productivity and global flows of trade and investment. We analyse and compare data to predict future trends. We set international standards on a wide range of things, from agriculture and tax to the safety of chemicals.
A sufficient number of animals should be used so that at the end of the study enough animals in every group are available for thorough biological evaluation. After considerable discussion, it was agreed that for rodents each dose group and concurrent control group should contain at least 10 animals of each sex.
Similarly, there is no firm recommendation for the use of specific strains as it is considered that at the present time the state of development testing provides no firm justification for such a recommendation.
In toxicity studies, Wistar Han (WH) and Sprague Dawley (SD) rat strains are both utilized and acceptable for EU and US test guidelines. In general, however, WH are preferentially used in Europe and SD rats are generally preferred in the US.